GleamWall
中文EN

TNON Tenon Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1560293 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY72.3%
TTM net income YoY-32.7%
TTM EPS YoY162.1%
Revenue 3-yr CAGR32.5%
Net income 3-yr CAGR—

Margins

Gross margin66.9%
Operating margin-225.9%
Net margin-305.1%
FCF margin-193.1%
EBITDA margin-220.7%

Returns

ROE-242.5%
ROA-128.0%
ROIC (approx.)-863.4%
Asset turnover0.42x

Leverage & solvency

Liabilities / assets43.1%
Debt / equity0.00x
Current ratio2.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-50.2%
Payout ratio—
Capex / revenue7.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.43M$1.28M$1.38M$1.48M$1.17M$564,000$726,000$770,000
Cost of revenue$482,000$465,000$434,000$464,000$400,000$319,000$403,000$417,000
Gross profit$950,000$814,000$945,000$1.02M$773,000$245,000$323,000$353,000
R&D expense$804,000$768,000$662,000$527,000$428,000$503,000$691,000$569,000
SG&A expense$1.52M$1.53M$1.71M$1.63M$2.20M$1.48M$1.66M$1.89M
Operating income-$3.08M-$3.35M-$3.28M-$2.87M-$3.39M-$2.86M-$3.68M-$3.17M
Interest expense$719,000$852,000$176,000————$0
Net income-$6.64M-$4.05M-$3.48M-$2.83M-$3.34M-$2.77M-$3.62M-$3.09M
EBITDA-$3.02M-$3.31M-$3.19M-$2.77M-$3.32M-$2.81M-$3.63M-$3.06M
EPS (basic)-5.39-12.35-0.31—-14.17-12.76-1.01—
EPS (diluted)-5.39-12.350.31—-14.17-12.761.01—
Weighted avg. shares (diluted)1,23132811,268—2362173,597—
Balance sheet
Cash & equivalents$8.27M$1.68M$4.61M$3.76M$3.44M$7.85M$10.31M$6.54M
Receivables$1.70M$1.95M$1.97M$1.70M$1.31M$770,000$886,000$863,000
Inventory$882,000$783,000$806,000$1.05M$1.36M$688,000$607,000$606,000
Current assets$11.22M$4.81M$7.62M$6.77M$6.54M$9.88M$11.99M$8.21M
PP&E, net$717,000$771,000$901,000$918,000$663,000$842,000$698,000$752,000
Goodwill$2.41M$2.41M$2.41M$2.41M$2.41M———
Intangibles$441,000$455,000$470,000$485,000$500,000———
Total assets$16.20M$9.92M$12.84M$10.76M$10.37M$11.11M$13.39M$9.84M
Current liabilities$3.83M$8.30M$7.41M$3.21M$3.04M$2.56M$2.19M$1.87M
Total liabilities$6.98M$11.66M$10.94M$5.72M$5.57M$4.40M$4.02M$3.87M
Shareholders' equity$9.22M-$1.74M$1.90M$5.04M$4.80M$6.71M$9.38M$5.97M
Shares outstanding2.68M330,67011.30M310,0368.61M7.59M7.59M3.14M
Cash flow statement
Operating cash flow-$2.39M-$2.76M-$2.96M-$2.22M-$3.82M-$2.21M-$2.48M-$2.78M
Capital expenditure$8,000$172,000$56,000$192,000-$111,000——-$37,000
Free cash flow-$2.40M-$2.93M-$3.02M-$2.42M-$3.71M——-$2.74M
Investing cash flow-$8,000-$172,000-$56,000-$192,000-$639,000——$37,000
Financing cash flow$8.99M$0$3.87M$2.73M$59,000-$59,000$6.26M$113,000
Depreciation & amortization$62,000$45,000$88,000$95,000$68,000$48,000$42,000$117,000
Stock-based compensation$120,000$412,000$331,000$344,000$58,000$417,000$872,000$883,000

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.